AbbVie adds EU approval for potential blockbuster psoriasis drug
The European Commission approves Skyrizi for use as a treatment for moderate to severe psoriasis, shortly after it received approval in the US.
Archives for May 2, 2019
Proposed Herceptin biosimilar to be marketed by Sandoz
Sandoz inks agreement with EirGenix to commercialize a Herceptin biosimilar currently in late-stage development.
Transgene and AZ to explore virus-based immunotherapies
The two companies will work to co-develop five oncolytic virus candidates through a collaborative research, option and licensing agreement.